Press releases
9 May 2016, Zwingenberg

BRAIN congratulates its NatLifE 2020 Partner Merck for Innovation Award

NatLifE-Coordinator BRAIN AG (ISIN DE0005203947 / WKN 520394), congratulates its strategic collaboration partner Merck to the 2016 BSB Innovation Award.

Oily, blemished skin is not only a problem during puberty. Adults also suffer from skin problems and acne. The proven effect concept of the cosmetic active ingredient developed by Merck together with BRAIN to care for skin with irritations also convinced the BSB Innovation Award jury.

“Together with Merck we are very pleased about this renowned award and would like to congratulate our strategic partner on that great success. It is a result of the intense and productive cooperation between the two partners within NatLifE 2020. Within only two years we managed to identify an innovative product candidate from the idea to the proven efficacy. Very shortly after having found these promising results our partner Merck noticed a broad interest from the cosmetic industry already”, says Dr. Michael Krohn, Executive VP BioActives Development at BRAIN. “For NatLifE this is the very first compound that made its way from early research along the value chain to the market. Our concept developed in the strategic alliance NatLifE 2020 works.”

RonaCare® SereneShield was jointly investigated in the first two years of the NatLifE 2020 programme and is a pioneer of Mercks dermocosmetics portfolio, which comprises selected active ingredients to provide care fon demanding skin. The product has a unique, special effect on the human skin. It readjusts the skins own microflora, reduces inflammation and besides also regulates sebum production.

The early research on the molecule was partly funded by the German Federal Ministry of Education and Research (BMBF) within the strategic alliance NatLifE 2020.

Share this page